Maximizing the Clinical Therapeutic Index of Antibody-drug Conjugates
The 10th World ADC San Diego was a roaring success. We reflected on what has been a rollercoaster of a decade, networked with industry leaders, learned from the best in the business and celebrated the hard work that has been put into the ADC field over the last 10 years.
It was great to see the community grow and continue to advance the development of antibody-drug conjugates at the industry-leading conference to help forward thinking researchers from the pharmaceutical, biotech and academic institutes.
We heard from 94 industry expert speakers. They shared detailed presentations over 4 streams, 3 focused seminar days and 9 interactive workshops, some highlights include:
- The patient perspective delivered by Matty Cragg, it was heartwarming to see his positive outlook and first had experience with ADCT-301
- An overview of the last 10 years and where the field is going, industry legend, John Lambert delivered an unforgettable history of the ADCs as well as a review of Mirvetuximab soravtansine
- The inaugural CMC Day was a great success with 9 presentations, a panel discussion the day was full of high level converse on how to advance late stage manufacturing process.
It was great to see over 600 attendees take advantage of this unrivalled learning and networking opportunity across four days. World ADC San Diego was packed with content and dedicated interactive formats, making sure that you leave equipped with the connections and takeaways you need to maximize the clinical therapeutic window of your ADC candidate.
Don’t miss the opportunity to join your fellow scientists at the heart of the ADC community in Europe.
For more details, visit: www.worldadc-europe.com
About World ADC Series
The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distill this into accessible formats of information exchange – for you. From globally leading conferences, to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.
We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.
Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs.